BASELINE CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH ANAEMIA IN CLINICAL STUDIES OF TOFACITINIB IN RHEUMATOID ARTHRITIS

被引:0
|
作者
Moeller, Burkhard [1 ]
Finckh, Axel [2 ]
Alvaro-Gracia, Jose-Maria [3 ]
Scholz, Godehard [1 ]
Aletaha, Daniel [4 ]
Biondo, Francesca [5 ]
Strengholt, Sander [6 ]
Luis Rivas, Jose [7 ]
Connell, Carol A. [8 ]
Shi, Harry [9 ]
机构
[1] Univ Hosp, Inselspital, Bern, Switzerland
[2] Univ Hosp Geneva, Geneva, Switzerland
[3] Hosp Univ La Princesa, Madrid, Spain
[4] Med Univ Vienna, Vienna, Austria
[5] Pfizer Inc, Rome, Italy
[6] Pfizer Inc, Capelle Aan Den Ijssel, Netherlands
[7] Pfizer SLU, Madrid, Spain
[8] Pfizer Inc, Groton, CT 06340 USA
[9] Pfizer Inc, Collegeville, PA USA
关键词
D O I
10.1136/annrheumdis-2019-eular.399
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0162
引用
收藏
页码:753 / 754
页数:2
相关论文
共 50 条
  • [21] The kinase inhibitor tofacitinib in patients with rheumatoid arthritis: latest findings and clinical potential
    Cutolo, Maurizio
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2013, 5 (01) : 3 - 11
  • [22] Clinical Management of Herpes Zoster in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Receiving Tofacitinib Treatment
    Winthrop, Kevin L.
    Curtis, Jeffrey R.
    Yamaoka, Kunihiro
    Lee, Eun Bong
    Hirose, Tomohiro
    Rivas, Jose L.
    Kwok, Kenneth
    Burmester, Gerd R.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (01) : 243 - 263
  • [23] Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program
    Mariette, Xavier
    Chen, Connie
    Biswas, Pinaki
    Kwok, Kenneth
    Boy, Mary G.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (05) : 685 - 694
  • [24] CLINICAL AND IMMUNOLOGICAL EFFECTS OF TOFACITINIB THERAPY IN RHEUMATOID ARTHRITIS
    Hamar, A.
    Pusztai, A.
    Vegh, E.
    Horvath, A.
    Gulyas, K.
    Szamosi, S.
    Petho, Z.
    Bodnar, N.
    Szanto, S.
    Szucs, G.
    Domjan, A.
    Nagy, G.
    Hodosi, K.
    Szekanecz, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : A59 - A60
  • [25] A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis
    Bannwarth, Bernard
    Kostine, Marie
    Poursac, Nicolas
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (06) : 753 - 761
  • [26] ANAEMIA OF RHEUMATOID ARTHRITIS - MORPHOLOGICAL AND FERROKINETIC STUDIES
    MUIRDEN, KD
    AUSTRALASIAN ANNALS OF MEDICINE, 1969, 18 (02): : 154 - &
  • [27] Sex differences in clinical characteristics and their influence on clinical outcomes in an observational cohort of patients with rheumatoid arthritis
    Shin, Seunghwan
    Park, Eun Hye
    Kang, Eun Ha
    Lee, Yun Jong
    Song, Yeong Wook
    Ha, You-Jung
    JOINT BONE SPINE, 2021, 88 (03)
  • [28] Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies
    Dikranian, Ara H.
    Gonzalez-Gay, Miguel A.
    Wellborne, Frank
    Alvaro-Gracia, Jose Maria
    Takiya, Liza
    Stockert, Lori
    Paulissen, Jerome
    Shi, Harry
    Tatulych, Svitlana
    Curtis, Jeffrey R.
    RMD OPEN, 2022, 8 (01):
  • [29] Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
    Clowse, Megan E. B.
    Feldman, Steven R.
    Isaacs, John D.
    Kimball, Alexandra B.
    Strand, Vibeke
    Warren, Richard B.
    Xibille, Daniel
    Chen, Yan
    Frazier, Donald
    Geier, Jamie
    Proulx, James
    Marren, Amy
    DRUG SAFETY, 2016, 39 (08) : 755 - 762
  • [30] Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
    Megan E. B. Clowse
    Steven R. Feldman
    John D. Isaacs
    Alexandra B. Kimball
    Vibeke Strand
    Richard B. Warren
    Daniel Xibillé
    Yan Chen
    Donald Frazier
    Jamie Geier
    James Proulx
    Amy Marren
    Drug Safety, 2016, 39 : 755 - 762